Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMarketsHome and away: Indian pharma firms reap the best of both worlds in Q1 FY24

    Home and away: Indian pharma firms reap the best of both worlds in Q1 FY24

    Improved pricing and competitive environment in the US and resilient sales in the domestic market aided an uptick in revenue. Easing raw material inflation and lower freight soothed margin pressure.

    Vaibhavi Ranjan
    August 30, 2023 / 11:45 IST
    Pharma companies posted more hits than misses in the Q1 earnings season.
    • PRO Panorama

      Moneycontrol Pro Panorama | What a December move by RBI, Fed means for the Indian economy

      Nov 26, 2025 / 03:06 PM IST

      In Moneycontrol Pro Panorama November 26 edition: For India, a rate cut right now is not just a monetary signal. It is a chance to...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts